Procedure for Stability Testing According to ICH Q1A(R2) in Hot Climates
1) Purpose
The purpose of this SOP is to define a procedure for implementing ICH Q1A(R2) guidelines for stability testing in tropical and subtropical regions. This ensures that drug products maintain their quality, safety, and efficacy under challenging climatic conditions.
2) Scope
This SOP applies to all personnel involved in the stability testing of drug products intended for distribution in tropical and subtropical climates, including formulation development, quality control, and regulatory affairs teams.
3) Responsibilities
Formulation Development Team: Responsible for developing formulations that are stable under hot and humid conditions.
Stability Study Team: Responsible for conducting stability studies according to ICH Q1A(R2) guidelines.
Regulatory Affairs Team: Responsible for ensuring compliance with regulatory requirements and submitting stability data to the relevant authorities.
4) Procedure
4.1 Protocol Development
4.1.1 Develop a stability testing protocol that includes specific conditions
for tropical and subtropical regions, such as 30°C/75% RH (Relative Humidity) and 40°C/75% RH for accelerated studies.4.1.2 Define storage conditions and testing intervals (e.g., 0, 3, 6, 12 months) according to ICH Q1A(R2) guidelines.
4.2 Sample Preparation and Storage
4.2.1 Prepare samples in their final packaging for stability testing, ensuring that packaging is suitable for hot and humid climates.
4.2.2 Store samples under specified conditions, using validated equipment to maintain temperature and humidity control.
4.3 Conducting Stability Tests
4.3.1 Perform stability tests at all required intervals, including assessments of physical, chemical, and microbiological properties.
4.3.2 Record all data accurately and ensure compliance with the approved protocol.
4.4 Data Analysis and Reporting
4.4.1 Analyze stability data to detect any trends or deviations that could impact product quality in tropical and subtropical climates.
4.4.2 Prepare a comprehensive stability report for regulatory submission, including all findings and conclusions.
5) Abbreviations, if any
ICH: International Council for Harmonisation
RH: Relative Humidity
6) Documents, if any
6.1 ICH Q1A(R2) guidelines
6.2 Stability testing protocols
6.3 Environmental monitoring records
7) Reference, if any
ICH Q1A(R2): Stability Testing of New Drug Substances and Products
8) SOP Version
Version 1.0

